| Primary |
| Nephrogenic Anaemia |
38.6% |
| Product Used For Unknown Indication |
25.4% |
| Hypertension |
11.1% |
| Anaemia |
4.4% |
| Renal Failure Chronic |
3.8% |
| Diabetes Mellitus |
2.1% |
| Drug Use For Unknown Indication |
2.0% |
| Prophylaxis |
1.8% |
| Hyperphosphataemia |
1.7% |
| Renal Failure |
1.3% |
| Gastritis |
1.1% |
| Hyperparathyroidism Secondary |
1.0% |
| Constipation |
0.9% |
| Hyperuricaemia |
0.9% |
| Hyperlipidaemia |
0.8% |
| Insomnia |
0.7% |
| Hepatitis C |
0.7% |
| Prophylaxis Against Transplant Rejection |
0.7% |
| Coronary Artery Disease |
0.6% |
| Oedema |
0.6% |
|
| Death |
50.2% |
| Haemoglobin Decreased |
15.4% |
| Anaemia |
4.6% |
| Pneumonia |
4.1% |
| Aplasia Pure Red Cell |
3.7% |
| Myocardial Infarction |
2.4% |
| Sepsis |
2.1% |
| Disease Progression |
1.8% |
| Cerebrovascular Accident |
1.7% |
| Renal Failure Chronic |
1.7% |
| Infection |
1.6% |
| Drug Ineffective |
1.5% |
| Cardiac Arrest |
1.3% |
| Renal Failure |
1.3% |
| Thrombocytopenia |
1.3% |
| Hypertension |
1.2% |
| Cardiac Failure |
1.1% |
| Cardio-respiratory Arrest |
1.1% |
| White Blood Cell Count Decreased |
1.1% |
| Cerebral Haemorrhage |
0.8% |
|
| Secondary |
| Nephrogenic Anaemia |
35.4% |
| Product Used For Unknown Indication |
13.3% |
| Hypertension |
9.3% |
| Anaemia |
6.0% |
| Hepatitis C |
4.0% |
| Liver Transplant |
3.5% |
| Prophylaxis |
3.2% |
| Renal Failure Chronic |
3.0% |
| Drug Use For Unknown Indication |
2.7% |
| Renal And Liver Transplant |
2.7% |
| Renal Failure |
2.6% |
| Hyperphosphataemia |
2.3% |
| Haemolytic Uraemic Syndrome |
2.2% |
| Transplant |
2.0% |
| Hyperuricaemia |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.4% |
| Diabetes Mellitus |
1.3% |
| Nephropathy |
1.3% |
| Hyperparathyroidism Secondary |
1.0% |
| Neutropenia |
0.9% |
|
| Death |
26.9% |
| Haemoglobin Decreased |
16.7% |
| Aplasia Pure Red Cell |
9.4% |
| Drug Ineffective |
8.3% |
| Anaemia |
8.0% |
| Pneumonia |
4.1% |
| Lung Infection |
3.2% |
| Therapeutic Response Decreased |
2.6% |
| Myocardial Infarction |
2.4% |
| Hyperkalaemia |
2.0% |
| Tachycardia |
2.0% |
| Carotid Artery Stenosis |
1.9% |
| Cerebral Ischaemia |
1.9% |
| Myelodysplastic Syndrome |
1.9% |
| Infection |
1.7% |
| Vomiting |
1.5% |
| Angina Pectoris |
1.4% |
| Myocarditis |
1.4% |
| Renal Failure |
1.4% |
| Spinal Compression Fracture |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.9% |
| Drug Use For Unknown Indication |
12.6% |
| Hypertension |
10.1% |
| Anaemia |
5.9% |
| Hyperparathyroidism Secondary |
4.4% |
| Renal Transplant |
4.2% |
| Chronic Hepatitis C |
3.6% |
| Hepatitis C |
3.6% |
| Hyperphosphataemia |
3.6% |
| Prophylaxis |
3.3% |
| Nephrogenic Anaemia |
3.2% |
| Peritoneal Dialysis |
3.0% |
| Renal Failure Chronic |
2.9% |
| Cardiac Failure |
2.4% |
| Coronary Artery Disease |
2.4% |
| Vitamin Supplementation |
2.1% |
| Hyperuricaemia |
1.8% |
| Anticoagulant Therapy |
1.7% |
| Atrial Fibrillation |
1.7% |
| Diabetes Mellitus |
1.5% |
|
| Drug Eruption |
11.8% |
| Death |
7.4% |
| Pulmonary Oedema |
7.4% |
| Thrombocytopenia |
7.4% |
| Urinary Tract Infection |
7.4% |
| Neoplasm Malignant |
5.9% |
| Sudden Death |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Anaemia |
4.4% |
| Atrial Fibrillation |
4.4% |
| Peritoneal Cloudy Effluent |
4.4% |
| Purpura |
4.4% |
| Abdominal Pain Upper |
2.9% |
| Acute Myocardial Infarction |
2.9% |
| Anal Squamous Cell Carcinoma |
2.9% |
| Asthenia |
2.9% |
| Bronchitis |
2.9% |
| Cardiac Failure |
2.9% |
| Diarrhoea |
2.9% |
| Flatulence |
2.9% |
|
